Lanzamiento Enero 2027

Ensayo controlado aleatorizado2006Financiación no declarada

Creatine supplementation improves muscle strength in patients with congestive heart failure

Kuethe F, Krack A, Richartz BM, Figulla HR

Die Pharmazie · 34 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2006-03-01 · Pharmazie · vol. 61 · número 3 · págs. 218–22
Editorial
National Institutes of Health
Citado
52 citas · más que el 76% de estudios similares · 1.2× el promedio de su campo
Referencias
0 trabajos
Acceso
De pago
Áreas de investigación
Muscle metabolism and nutrition · Heart Failure Treatment and Management · Cardiovascular and exercise physiology
Palabras clave
creatine supplementation, congestive heart failure, muscle strength, peak oxygen uptake, anaerobic threshold, 6-minute walk test, quality of life, body weight, exercise capacity
MeSH
elbow, muscle, skeletal, humans, creatine, ultrasonography, walking, cross-over studies, double-blind method, oxygen consumption, quality of life, physical fitness, dietary supplements, aged, female, male, heart failure, surveys and questionnaires

4 autores

  • Friedhelm Kuethe🇩🇪Friedrich Schiller University Jena
  • Andreas Krack
  • Barbara Maria Richartz
  • Hans Reiner Figulla

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Both, cardiac and skeletal muscle creatine levels are depressed in patients with congestive heart failure (CHF). Oral supplementation of creatine (Cr) could increase physical performance in healthy volunteers. We therefore hypothesized that oral creatine supplementation improves skeletal muscle strength, quality of live and symptom-limited performance in patients with CHF.

Methods

In a double-blind, placebo-controlled and crossover-designed study, 20 patients suffering from congestive heart failure more than 6 months and a peak oxygen uptake (peak VO2) below 20 ml/min/kg received 4 x 5 g Cr daily vs. placebo for 6 weeks and were crossed over for the following 6 weeks. Peak VO2, VO2 at the anaerobic threshold (VO2AT), ejection fraction (EF), distance in 6-minute-walk-test (6 min W), and muscle strength (Modified Sphygmomanometer (MS)) were determined at baseline, after 6, and after 12 weeks. Dyspnoea after 6-minute-walk-test was measured using the Borg Scale. Quality of live was assessed with the Minnesota Living with Heart Failure Questionnaire (MLHFQ).

Results

13 of 20 Patients finished the study. After 6 weeks of creatine supplementation there was a significant increase in body weight and muscle strength compared to baseline and placebo (p < 0.05). However, there was no significant change in peak VO2, VO2AT, walking distance, quality of life assessment and EF.

Conclusion

Short-term creatine supplementation inaddition to standard medication in patients with CHF leads to an increase in body weight and an improvement of muscle strength. This effect is restricted to the time of supplementation.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.